Early adverse events and patient-reported outcomes after salvage radiotherapy following prostatectomy according to fractionation schedule: Interim analysis of the phase III URONCOR 06–24 trial
Loading...
Identifiers
Publication date
Authors
Advisors
Editors
Journal Title
Journal ISSN
Volume Title
Publisher
SDG
Metrics
Abstract
Moderate hypofractionation is increasingly used in salvage radiotherapy (SRT) after radical prostatectomy, although prospective data in the postoperative setting remain limited. We evaluated early adverse events and patient-reported outcomes (PROs) according to fractionation schedule within a prospective multicenter phase III trial.
Description
UNESCO Subjects
Keywords
Bibliographic reference
Couñago, F., González, C., Gómez-Iturriaga, A., Álvarez, A., Santos, M., Boladeras, A., García, N., Fernández, S., Guardado, S., Ocanto, A., Gonsalves, D., Glaría, L., Castaño, A., Martín, P., Montezuma, L., Mera, A., Mases, J., Meca, G., Duque-Santana, V., … López-Campos, F. (2026). Early adverse events and patient-reported outcomes after salvage radiotherapy following prostatectomy according to fractionation schedule: Interim analysis of the phase III URONCOR 06–24 trial. Clinical and Translational Radiation Oncology, 61, 101276. https://doi.org/10.1016/j.ctro.2026.101276
Editor's version
https://doi.org/10.1016/j.ctro.2026.101276Type of document
Collections
La licencia de este ítem se describe como Attribution 4.0 International